Top Big Cap Positive News Movers Premarket:  SNOW: +24% Earnings NTSK: +13% Earnings HCM: +12% Licensing Agreement with GSK for KRAS-EGFR-Antibody Conjugate Cancer Therapy SMMT: +6.5% Ivonescimab Monotherapy Demonstrates Statistically Significant Overall Survival Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in HARMONi-2 Study  FIVE: +3% Earnings MIR: +2% Initiated BUY @ Jefferies 03-SEP-2026 09:08 AM ET